Comments: US HB6301 | 2023-2024 | 118th Congress

Bill Title: Cancer Drug Parity Act of 2023

Spectrum: Moderate Partisan Bill (Democrat 22-4)

Status: (Introduced) 2023-11-08 - Referred to the House Committee on Education and the Workforce. [HB6301 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB6301 at this time.

Social Comments on US HB6301

feedback